Posters

Our postoperative results of retropupillar iris-claw lens implantation in pediatric aphakic patients without capsular support

Poster Details

First Author: E.Demirkilinc Biler TURKEY

Co Author(s):    S. Egrilmez   O. Uretmen   S. Kose        

Abstract Details

Purpose:

To evaluate the post operative results and complications after retropupillary implantation of an iris-claw aphakic intraocular lens (IOL) in pediatric cases.

Setting:

Ege University Faculty of Medicine, Ophthalmology Department

Methods:

Seven eyes of 4 children aged 6 to 16 years who underwent posterior chamber iris-claw aphakic IOL implantation between 2012 and 2013 were enrolled in the study. No adequate capsular support was present in any cases. Pre and post operative visual acuity with and without distance correction, endothelial cell changes, intraoperative and postoperative complications and post operative macular OCT findings were evaluated.

Results:

Two boys and 2 girls were enrolled in the study. The mean age was 11.4±3.9 and the mean follow up period was 15.6±6 (8-22) months. Pre-operative mean best corrected visual acuity (BCVA) was 0.7±0.2 and the post-operative mean BCVA was 0.88±0.17 at the last follow-up. Although the mean change seemed to be clinically important, it was statistically insignificant (p=0.061; Wilcoxon signed rank test). The mean endothelial cell density change could be evaluated in only 3 eyes and decreased from 2947 cellss/mm2 preoperatively to 2840 cells/mm2 at last follow-up, representing a mean endothelial cell loss of 3.6%. No corneal decompensation, iritis, secondary glaucoma, or pupillary block occurred after surgery in any eye. Postoperative complications were a traumatic dislocation of a posterior aphakic iris-claw IOL in 1 eye and transient anterior segment enflamation which completely resolved with the systemic corticosteroid therapy in 1 eye.

Conclusions:

Retropupillar implantation of aphakic iris-claw IOL in pediatric age group, provided good visual outcomes with a favorable complication rate and seems to be a reasonable alternative in pediatric eyes without adequate capsular support. Long term comparative studies with big case series are needed to show the safety and efficacy in this age group. FINANCIAL INTEREST: NONE